MALARIA (PLASMODIUM FALCIPARUM)
Clinical trials for MALARIA (PLASMODIUM FALCIPARUM) explained in plain language.
Never miss a new study
Get alerted when new MALARIA (PLASMODIUM FALCIPARUM) trials appear
Sign up with your email to follow new studies for MALARIA (PLASMODIUM FALCIPARUM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double vaccine attack on malaria shows promise in early trial
⭐️ VACCINE ⭐️ CompletedThis study tested two different malaria vaccines—one targeting the blood stage and one the liver stage—alone and in combination. 107 healthy adults and infants in The Gambia received the vaccines to check safety and immune response. The goal is to see if combining them offers bet…
Matched conditions: MALARIA (PLASMODIUM FALCIPARUM)
Phase: PHASE1 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:31 UTC
-
Malaria drug resistance confirmed in ethiopia: study raises alarm
Knowledge-focused CompletedThis study looked at whether the malaria parasite in Ethiopia is becoming resistant to artemisinin, the main drug used to treat it. Researchers tested 277 patients across five sites, checking if parasites were still in the blood three days after treatment and looking for a specif…
Matched conditions: MALARIA (PLASMODIUM FALCIPARUM)
Phase: NA • Sponsor: Didier Menard • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC